FDA Commissioner Marty Makary (Bill Clark/CQ Roll Call via AP Images)
Makary, in one of first comments on FDA policy, floats new pathway for rare disease drugs
It’s been a little more than two weeks since Marty Makary took over as FDA commissioner and already he’s announcing plans for a new, customized …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
